SLC35A2

solute carrier family 35 member A2
OMIM: 314375, ClinGen, DECIPHER

9 panels

Panel Reviews Mode of inheritance Details
9 panels

Green SLC35A2 in Tuberous Sclerosis_Focal Cortical Dysplasia_Hemimegalencephaly


Level 2: Neurology and neurodevelopmental disorders
Version 1.0

2 reviews X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)
Sources
  • Expert Review Green
  • Literature
Phenotypes
  • Mild malformation of cortical development with oligodendroglial hyperplasia in epilepsy (MOGHE)
Tags
  • somatic

Green SLC35A2 in Congenital Disorders of Glycosylation


Level 2: Metabolic disorders
Version 2.0

1 review X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)
Sources
  • Expert Review Green
  • Victorian Clinical Genetics Services
Phenotypes
  • Congenital disorder of glycosylation, type IIm (MIM #300896)

Red SLC35A2 in Cerebral Palsy


Level 2: Neurology and neurodevelopmental disorders
Version 2.0

1 review X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)
Sources
  • Expert Review Red
  • Literature
Phenotypes
  • Congenital disorder of glycosylation, type IIm, MIM#300896

Green SLC35A2 in Mendeliome


Version 2.0

1 review X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)
Sources
  • Expert Review Green
  • Victorian Clinical Genetics Services
Phenotypes
  • Congenital disorder of glycosylation, type IIm (MIM #300896) 30817854
  • Mild malformation of cortical development with oligodendroglial hyperplasia in epilepsy (MOGHE)
Tags
  • somatic

Green SLC35A2 in Genetic Epilepsy


Level 2: Neurology and neurodevelopmental disorders
Version 2.0

1 review X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)
Sources
  • Expert Review Green
  • Victorian Clinical Genetics Services
  • Australian Genomics Health Alliance Epilepsy Flagship
  • Victorian Clinical Genetics Services
Phenotypes
  • Congenital disorder of glycosylation, type IIm (MIM #300896) 30817854
  • Mild malformation of cortical development with oligodendroglial hyperplasia in epilepsy (MOGHE)

Green SLC35A2 in Intellectual disability syndromic and non-syndromic


Level 2: Neurology and neurodevelopmental disorders
Version 2.0

1 review X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)
Sources
  • Expert Review Green
  • Genetic Health Queensland
Phenotypes
  • Congenital disorder of glycosylation, type IIm (MIM #300896) 30817854
  • Mild malformation of cortical development with oligodendroglial hyperplasia in epilepsy (MOGHE)
Tags
  • somatic

Red SLC35A2 in Additional findings_Paediatric


Level 2: Screening
Version 1.0

0 reviews X-LINKED: hemizygous mutation in males, biallelic mutations in females
Sources
  • Expert Review Red
  • BabySeq Category C gene
Phenotypes
  • Early-onset epileptic encephalopathy

Green SLC35A2 in Fetal anomalies


Version 2.0

2 reviews X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)
Sources
  • Expert Review Green
  • Genomics England PanelApp
Phenotypes
  • Congenital disorder of glycosylation, type IIm (MIM #300896)

Green SLC35A2 in Genomic newborn screening: BabyScreen+


Level 2: Screening
Version 2.0

1 review X-LINKED: hemizygous mutation in males, biallelic mutations in females
Sources
  • Expert Review Green
  • BabySeq Category C gene
Phenotypes
  • Congenital disorder of glycosylation, type IIm, MIM #300896
Tags
  • treatable
  • metabolic